Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 701970, 7 pages
http://dx.doi.org/10.1155/2013/701970
Review Article

Development and Treatments of Inflammatory Cells and Cytokines in Spinal Cord Ischemia-Reperfusion Injury

1Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou 510100, China
2National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan
3National Institute of Infectious Diseases, Tokyo, Japan

Received 30 April 2013; Accepted 24 June 2013

Academic Editor: Geeta Ramesh

Copyright © 2013 Ping Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Hasturk, B. Atalay, T. Calisaneller, O. Ozdemir, H. Oruckaptan, and N. Altinors, “Analysis of serum pro-inflammatory cytokine levels after rat spinal cord ischemia/reperfusion injury and correlation with tissue damage,” Turkish Neurosurgery, vol. 19, no. 4, pp. 353–359, 2009. View at Google Scholar · View at Scopus
  2. J. C. Papakostas, M. I. Matsagas, I. K. Toumpoulis et al., “Evolution of spinal cord injury in a porcine model of prolonged aortic occlusion,” Journal of Surgical Research, vol. 133, no. 2, pp. 159–166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Tsuruta, M. Matsumoto, S. Fukuda et al., “The effects of cyclosporin A and insulin on ischemic spinal cord injury in rabbits,” Anesthesia and Analgesia, vol. 102, no. 6, pp. 1722–1727, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Savaş, N. Delibaş, Ç. Savaş, R. Sütçü, and A. Cindaş, “Pentoxifylline reduces biochemical markers of ischemia-reperfusion induced spinal cord injury in rabbits,” Spinal Cord, vol. 40, no. 5, pp. 224–229, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Öz Oyar, A. Korkmaz, Ö. Kardesş, and S. Ömeroǧlu, “Aortic cross-clamping-induced spinal cord oxidative stress in rabbits: the role of a novel antioxidant adrenomedullin,” Journal of Surgical Research, vol. 147, no. 1, pp. 143–147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Temiz, I. Solmaz, O. Tehli et al., “The effects of splenectomy on lipid peroxidation and neuronal loss in experimental spinal cord ischemia/reperfusion injury,” Turkish Neurosurgery, vol. 23, pp. 67–74, 2013. View at Google Scholar
  7. T. B. Reece, D. O. Okonkwo, P. I. Ellman et al., “The evolution of ischemic spinal cord injury in function, cytoarchitecture, and inflammation and the effects of adenosine A2A receptor activation,” Journal of Thoracic and Cardiovascular Surgery, vol. 128, no. 6, pp. 925–932, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Kang, H. Albadawi, P. J. Casey et al., “The effects of systemic hypothermia on a murine model of thoracic aortic ischemia reperfusion,” Journal of Vascular Surgery, vol. 52, no. 2, pp. 435–443, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. H. H. Oruckaptan, P. Ozisik, P. Atilla et al., “Systemic administration of interleukin-10 attenuates early ischemic response following spinal cord ischemia reperfusion injury in rats,” Journal of Surgical Research, vol. 155, no. 2, pp. 345–356, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Akuzawa, T. Kazui, E. Shi, K. Yamashita, A. H. M. Bashar, and H. Terada, “Interleukin-1 receptor antagonist attenuates the severity of spinal cord ischemic injury in rabbits,” Journal of Vascular Surgery, vol. 48, no. 3, pp. 694–700, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Nakata, K. Kawachi, M. Nagashima et al., “Transient ischemia-induced paresis and complete paraplegia displayed distinct reactions of microglia and macrophages,” Brain Research, vol. 1420, pp. 114–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Matsumoto, M. Matsumoto, A. Yamashita et al., “The temporal profile of the reaction of microglia, astrocytes, and macrophages in the delayed onset paraplegia after transient spinal cord ischemia in rabbits,” Anesthesia and Analgesia, vol. 96, no. 6, pp. 1777–1784, 2003. View at Google Scholar · View at Scopus
  13. K. Okajima, “Prevention of endothelial cell injury by activated protein C: the molecular mechanism(s) and therapeutic implications,” Current Vascular Pharmacology, vol. 2, no. 2, pp. 125–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Nakayama, N. Harada, M. Asano et al., “Atrial natriuretic peptide reduces ischemia/reperfusion-induced spinal cord injury in rats by enhancing sensory neuron activation,” Journal of Pharmacology and Experimental Therapeutics, vol. 322, no. 2, pp. 582–590, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. K. Olson, “Immune response by microglia in the spinal cord,” Annals of the New York Academy of Sciences, vol. 1198, pp. 271–278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Tikka, B. L. Fiebich, G. Goldsteins, R. Keinänen, and J. Koistinaho, “Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia,” Journal of Neuroscience, vol. 21, no. 8, pp. 2580–2588, 2001. View at Google Scholar · View at Scopus
  17. P. D. Smith, F. Puskas, X. Meng et al., “The evolution of chemokine release supports a bimodal mechanism of spinal cord ischemia and reperfusion injury,” Circulation, vol. 126, pp. S110–S117, 2012. View at Google Scholar
  18. N. Ning, X. Dang, C. Bai, C. Zhang, and K. Wang, “Panax notoginsenoside produces neuroprotective effects in rat model of acute spinal cord ischemia-reperfusion injury,” Journal of Ethnopharmacology, vol. 139, no. 2, pp. 504–512, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Lu, C.-L. Cho, C.-L. Liang et al., “Inhibition of the MEK/ERK pathway reduces microglial activation and interleukin-1-beta expression in spinal cord ischemia/reperfusion injury in rats,” Journal of Thoracic and Cardiovascular Surgery, vol. 133, no. 4, pp. 934–941, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Kunihara, S. Sasaki, N. Shiiya, T. Miyatake, N. Mafune, and K. Yasuda, “Proinflammatory cytokines in cerebrospinal fluid in repair of thoracoabdominal aorta,” Annals of Thoracic Surgery, vol. 71, no. 3, pp. 801–806, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Hirose, K. Okajima, Y. Taoka et al., “Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation,” Annals of Surgery, vol. 232, no. 2, pp. 272–280, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Guven, A. O. Borcek, B. Cemil et al., “Neuroprotective effects of infliximab in experimental spinal cord ischemic injury,” Journal of Clinical Neuroscience, vol. 17, no. 12, pp. 1563–1567, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Fan, K. Wang, Z. Shi, J. Die, C. Wang, and X. Dang, “Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury,” Journal of Vascular Surgery, vol. 54, no. 1, pp. 192–200, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Zhang, C. Huang, B. Meng, T. Tang, Q. Shi, and H. Yang, “Acute effect of ghrelin on ischemia/reperfusion injury in the rat spinal cord,” International Journal of Molecular Sciences, vol. 13, pp. 9864–9876, 2012. View at Google Scholar
  25. C.-J. Lee, K.-W. Kim, H.-M. Lee et al., “The effect of thalidomide on spinal cord ischemia/reperfusion injury in a rabbit model,” Spinal Cord, vol. 45, no. 2, pp. 149–157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. G. E. Hermann, R. C. Rogers, J. C. Bresnahan, and M. S. Beattie, “Tumor necrosis factor-α induces cFOS and strongly potentiates glutamate-mediated cell death in the rat spinal cord,” Neurobiology of Disease, vol. 8, no. 4, pp. 590–599, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Lu, C.-L. Liang, P.-C. Liliang et al., “Inhibition of extracellular signal-regulated kinases 1/2 provides neuroprotection in spinal cord ischemia/reperfusion injury in rats: relationship with the nuclear factor-κB-regulated anti-apoptotic mechanisms,” Journal of Neurochemistry, vol. 114, no. 1, pp. 237–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. J. A. Plunkett, C.-G. Yu, J. M. Easton, J. R. Bethea, and R. P. Yezierski, “Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat,” Experimental Neurology, vol. 168, no. 1, pp. 144–154, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. J. R. Hu, G. H. Lv, and B. L. Yin, “Altered microRNA expression in the ischemic-reperfusion spinal cord with atorvastatin therapy,” Journal of Pharmacological Sciences, vol. 121, pp. 343–346, 2013. View at Google Scholar
  30. C. M. Bhamidipati, G. S. Mehta, C. W. Moehle et al., “Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysms,” The FASEB Journal, vol. 27, no. 6, pp. 2122–2131, 2013. View at Google Scholar
  31. D. C. Cassada, C. G. Tribble, S. M. Long et al., “Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-α and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia,” Journal of Vascular Surgery, vol. 35, no. 5, pp. 994–998, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. D.-J. Zhu, B. Xia, Q. Bi, S.-J. Zhang, B.-S. Qiu, and C. Zhao, “Functional protection of pentoxifylline against spinal cord ischemia/reperfusion injury in rabbits: necrosis and apoptosis effects,” Chinese Medical Journal, vol. 121, no. 23, pp. 2444–2449, 2008. View at Google Scholar · View at Scopus
  33. Y. Huang, K. Xie, J. Li et al., “Beneficial effects of hydrogen gas against spinal cord ischemia-reperfusion injury in rabbits,” Brain Research, vol. 1378, pp. 125–136, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Gong, L.-B. Yuan, L. Hu et al., “Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1,” Acta Pharmacologica Sinica, vol. 33, no. 1, pp. 11–18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Fang, H. Wang, X. J. Sun et al., “Intrathecal transplantation of bone marrow stromal cells attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury in rabbits,” Journal of Vascular Surgery, 2013. View at Publisher · View at Google Scholar
  36. K. Hirose, K. Okajima, Y. Taoka et al., “Antithrombin reduces the ischemia/reperfusion-induced spinal cord injury in rats by attenuating inflammatory responses,” Thrombosis and Haemostasis, vol. 91, no. 1, pp. 162–170, 2004. View at Google Scholar · View at Scopus
  37. I. Fansa, M. E. Altug, I. Melek et al., “The neuroprotective and anti-inflammatory effects of diltiazem in spinal cord ischaemia—reperfusion injury,” Journal of International Medical Research, vol. 37, no. 2, pp. 520–533, 2009. View at Google Scholar · View at Scopus
  38. T. Kunihara, S. Sasaki, N. Shiiya et al., “Lazaroid reduces production of IL-8 and IL-1 receptor antagonist in ischemic spinal cord injury,” Annals of Thoracic Surgery, vol. 69, no. 3, pp. 792–798, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Geiler, M. Buch, and M. F. Mcdermott, “Anti-TNF treatment in rheumatoid arthritis,” Current Pharmaceutical Design, vol. 17, no. 29, pp. 3141–3154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Maggi, A. Vultaggio, and A. Matucci, “Acute infusion reactions induced by monoclonal antibody therapy,” Expert Review of Clinical Immunology, vol. 7, no. 1, pp. 55–63, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. C. H. Chung, “Managing premedications and the risk for reactions to infusional monoclonal antibody therapy,” The Oncologist, vol. 13, no. 6, pp. 725–732, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. H.-J. Lenz, “Management and preparedness for infusion and hypersensitivity reactions,” The Oncologist, vol. 12, no. 5, pp. 601–609, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Goldbach-Mansky, “Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1,” Clinical and Experimental Immunology, vol. 167, no. 3, pp. 391–404, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Kaiser, A. Knight, D. Nordström et al., “Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations,” Rheumatology International, vol. 32, no. 2, pp. 295–299, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Ledent, J.-M. Vaugeoist, S. N. Schiffmann et al., “Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A(2a) receptor,” Nature, vol. 388, no. 6643, pp. 674–678, 1997. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Ohno, M. Ito, M. Ichihara, and M. Ito, “Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 353152, 11 pages, 2012. View at Publisher · View at Google Scholar
  47. K. Korkmaz, H. S. Gedik, A. B. Budak, H. Erdem, G. Lafci, E. Karakilic et al., “Effect of heparin on neuroprotection against spinal cord ischemia and reperfusion in rats,” European Review For Medical and Pharmacological Sciences, vol. 17, pp. 522–530, 2013. View at Google Scholar
  48. F. Simon, A. Scheuerle, M. Gröger et al., “Comparison of carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury,” Intensive Care Medicine, vol. 37, no. 9, pp. 1525–1533, 2011. View at Publisher · View at Google Scholar · View at Scopus